e-Therapeutics (ETX)

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

37.25p
   
  • Change Today:
      0.75p
  • 52 Week High: 44.00p
  • 52 Week Low: 25.25p
  • Currency: UK Pounds
  • Shares Issued: 13.13m
  • Volume: 44,056
  • Market Cap: £4.89m

e-Therapeutics Overview

e-Therapeutics is in the pharmaceuticals & biotechnology sector and is currently trading at 37.25p per share. In the last year e-Therapeutics's share price has ranged from 25.25p to 44.00p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 1.8%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 0.3  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

e-Therapeutics Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Jan-08 0.06 (2.22) (3.81)p n/a n/a n/a n/a 0.0%
31-Jan-09 0.07 (1.96) (2.76)p n/a n/a n/a n/a 0.0%
31-Jan-10 n/a (2.26) (2.96)p n/a n/a n/a n/a 0.0%
31-Jan-11 n/a (2.65) (3.51)p n/a n/a n/a n/a 0.0%
31-Jan-12 n/a (3.86) (2.47)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

e-Therapeutics Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Jan-13 n/a (5.84) (3.82)p n/a n/a n/a 0.67p 1.8%
31-Jan-14 n/a (4.11) (2.37)p n/a n/a n/a 2.00p 5.3%

Copyright © 2012 FactSet Research Systems Inc. All rights reserved.

e-Therapeutics Company Announcements

e-Therapeutics' Preliminary Results for the Year... 22-May-2012 07:03 Business Wire
Notice of Results 10-May-2012 07:00 RNS
Director/PDMR Shareholding 04-May-2012 18:00 RNS

e-Therapeutics ShareCast News

Bramson vehicle buys more shares in F&C 15-Mar-2011 ShareCast
Wife of outgoing FD sells British Land shares 14-Mar-2011 ShareCast
Shaftesbury boss invests £100,000 04-Mar-2011 ShareCast

Latest e-Therapeutics Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

e-Therapeutics Market Data

Currency UK Pounds
Share Price 37.25p
Change Today 0.75p
% Change 2.05 %
52 Week High 44.00p
52 Week Low 25.25p
Volume 44,056
Shares Issued 13.13m
Market Cap £4.89m

e-Therapeutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47.30% above the market average47.30% above the market average47.30% above the market average47.30% above the market average47.30% above the market average
56.52% above the sector average56.52% above the sector average56.52% above the sector average56.52% above the sector average56.52% above the sector average
Price Trend
60.98% above the market average60.98% above the market average60.98% above the market average60.98% above the market average60.98% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

e-Therapeutics Dividends

No dividends found

Trades for 31-May-2012

Time Volume / Share Price
16:18 854 @ 37.80p
12:48 217 @ 37.80p
11:23 1,157 @ 36.50p
11:11 7,500 @ 37.75p
09:08 10,000 @ 37.35p

e-Therapeutics Key Personnel

CEO Professor Malcolm Young
CFO Daniel Elger

Top of Page